1.02
1.02 (0%)
As of May 24, 2024
Ys Biopharma Co., Ltd. [YS]
Source:
Company Overview
Lakeshore Biopharma Co., Ltd is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer.
| Country | United States |
| Headquarters | beijing |
| Phone Number | 010-89202086 |
| Industry | manufacturing |
| CEO | Dave Chenn & Dr. Hui Shao |
| Website | www.lakeshorebio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $80.8 |
| Operating Profit | $-445.8 |
| Net Income | $-433.5 |
| Net Cash | $-123.8 |
Profit Ratios
| Gross Margin | $455.7 |
| Operating Margin | -551.6 |
| Profit as % of Revenues | -105.1% |
| Profit as % of Assets | -54.4% |
| Profit as % of Stockholder Equity | -74.1% |
Management Effectiveness
| Return on Equity | -74.1% |
| Return on Assets | -28.7% |
| Turnover Ratio | 10.1% |
| EBITA | $-445.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,513 |
| Total Liabilities | $927.8 |
| Operating Cash Flow | $-295.2 |
| Investing Cash Flow | $-44.3 |
| Financing Cash Flow | $205.3 |
